Notice & Comment

Notice & Comment

Notice & Comment

The Other Birthright Citizenship Question—Who Decides?, by Gillian Chadwick & David S. Rubenstein

President Trump sparked a frantic response from advocates and scholars this week when he announced that he could terminate birthright citizenship for children of undocumented parents with an executive order. The bulk of that response has focused on the question of what the Constitution means with respect to birthright citizenship. The other question raised by […]

Notice & Comment

Bureaucratic Assistance

We just wrapped up the American Bar Association’s annual Administrative Law Conference, which was a terrific event and broke records with more than 700 adlaw geeks in attendance. I had the privilege of moderating the final panel of the conference, focused on the future of the federal civil service. We had a terrific panel and […]

Notice & Comment

Judges Shouldn’t Have the Power to Halt Laws Nationwide

That’s the headline to an article of mine, co-authored with Sam Bray of Notre Dame Law School and published today in The Atlantic. We highlight the disquieting possibility that a single district court in Texas might soon enter an injunction prohibiting the enforcement of all or part of the Affordable Care Act across the entire […]

Notice & Comment

How Democrats Can Oppose the Republicans Only Judicial Hearings

Even though the U.S. Senate is on recess, Senate Republicans held hearings on judicial nominees, which only Senate Republicans attended. Senate Democrats opposed the hearings as an attempt to prevent serious questioning of the nominees. Unlike the Brett Kavanagh nomination, Senate Democrats have several ways to prevent most of the nominees from being confirmed. First, […]

Notice & Comment

Mandating Drug Price Transparency (Part II)

Drug prices have captured political leaders’ attention.  See, e.g., Robert Pear, Big Pharma’s Nightmare: Trump Crossing the Aisle to Curb Drug Prices, N.Y.TIMES A23 (Oct. 21, 2018); Robert Langreth, Quicktake: Drug Prices, BLOOMBERG (Jan. 25, 2016)(updated May 11, 2018).  On October 11, 2018, the Centers for Medicare and Medicaid Services (“CMS”) took a modest step […]

Notice & Comment

A Day in the Life of an Administrative Law Nerd, by Kathryn E. Kovacs

When my conference was canceled, I rejoiced. A free day in Washington, D.C.! The last time I was in Washington, an unprecedented windstorm foiled my plans. This time, hurricane Florence was bearing down on the Carolinas, but it turned away from Washington. It was meant to be: a day at the National Archives and the […]

Notice & Comment

Mandating Drug Price Transparency (Part I)

On October 11, 2018, the Centers for Medicare and Medicaid Services (“CMS”) proposed a requirement that direct-to-consumer (DTC) television advertisements for prescription drugs or biological products (“biologics”) include the product’s “list price.” Regulation to Require Drug Pricing Transparency, 52 Fed. Reg. 52789 (Oct. 18, 2018).  The “Regulation to Require Drug Pricing Transparency,” 42 C.F.R. §§403.1200 to […]

Notice & Comment

Fallout from Lucia – Radioactive?, by William Funk

Readers of Notice & Comment are undoubtedly familiar with Lucia v. Securities and Exchange Commission, in which the Supreme Court held that Administrative Law Judges (ALJs) in the SEC were inferior officers, not employees. As a result, they had to be appointed in accordance with the Appointments Clause of the Constitution. In relevant part, that […]

Notice & Comment

Bad Faith and the Record Rule

There has been a recent explosion of disputes in which the Supreme Court must decide when there is evidence of bad faith that is powerful enough to justify a reviewing court’s decision to allow a petitioner to rely on extra-record evidence or to develop extra-record evidence as part of the basis for review of an […]

Notice & Comment

Oh SNAP!: A Battle Over “Food Stamp” Redemption Data That May Radically Reshape FOIA Exemption 4 (Part IV)

This post concludes a four-part series prompted by the Supreme Court’s stay of the Eighth Circuit’s mandate in Food Marketing Institute v. Argus Leader Media, 889 F.3d 914 (2018).  The first four posts (available here, here, here, and here) addressed the Food Marketing Institute’ frontal assault on the National Parks test for identifying “confidential” commercial […]